Estelle G. McLean

Characterization of p53 Wild-Type and Null Isogenic Colorectal Cancer Cell Lines Resistant to 5-Fluorouracil, Oxaliplatin, and Irinotecan

John Boyer, Estelle G. McLean, Somaiah Aroori et al. · Clinical Cancer Research · 2004 · 224 citations

Medicine, Cancer Biology, Pharmacology +16

Kinetic and Structural Characteristics of the Inhibition of Enoyl (Acyl Carrier Protein) Reductase by Triclosan

Walter H.J. Ward, Geoffrey A. Holdgate, Siân Rowsell et al. · Biochemistry · 1999 · 160 citations

Life Sciences, Biochemistry, Pharmacology +17

Pharmacogenomic Identification of Novel Determinants of Response to Chemotherapy in Colon Cancer

John Boyer, Wendy L. Allen, Estelle G. McLean et al. · Cancer Research · 2006 · 106 citations

Medicine, Oncology, Pharmacology +17

The role of spermidine/spermine<i>N</i>1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells

Wendy L. Allen, Estelle G. McLean, John Boyer et al. · Molecular Cancer Therapeutics · 2007 · 47 citations

Medicine, Molecular Biology, Oncology +9

Prostate-derived factor—a novel inhibitor of drug-induced cell death in colon cancer cells

Irina Proutski, Leanne Stevenson, Wendy L. Allen et al. · Molecular Cancer Therapeutics · 2009 · 20 citations

Medicine, Oncology, Pharmacology +17